breast cancer
Conditions
Interventions
Test group:Fulvestrant
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed advanced breast cancer, including inoperable locally advanced breast cancer, newly diagnosed stage IV (staging according to AJCC 8th Edition), or recurrent / metastatic breast cancer; 2. Estrogen receptor (ER) positive and (or) progesterone (PR) receptor positive; 3. Had at least one measurable lesion (RECIST 1.1); 4. The patient voluntarily joined this project to sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. HER2 overexpression or gene amplification, such as immunohistochemical detection of HER2 (3 +) or fluorescence in situ hybridization positivity; 3. Serious harms to patient safety or concomitant diseases affecting the completion of the study by the patient, as judged by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective response rate;Overall Survival time;Treatment failure time; | — |
Countries
China
Contacts
Public ContactZhong Jincai, Deng Lili
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed